Ocular Adhesives and Sealants

Global Ocular Adhesives and Sealants Market to Reach US$242.5 Million by 2030

The global market for Ocular Adhesives and Sealants estimated at US$168.4 Million in the year 2024, is expected to reach US$242.5 Million by 2030, growing at a CAGR of 6.3% over the analysis period 2024-2030. Natural Ocular Adhesives & Sealants, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$150.1 Million by the end of the analysis period. Growth in the Synthetic Ocular Adhesives & Sealants segment is estimated at 8.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$45.9 Million While China is Forecast to Grow at 9.7% CAGR

The Ocular Adhesives and Sealants market in the U.S. is estimated at US$45.9 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$49.2 Million by the year 2030 trailing a CAGR of 9.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Global Ocular Adhesives and Sealants Market – Key Trends & Drivers Summarized

Why Are Ocular Adhesives and Sealants Gaining Traction as a Surgical Alternative to Sutures?

Ocular adhesives and sealants are rapidly transforming ophthalmic surgery by offering a safer, faster, and less invasive alternative to traditional suturing methods. These specialized biomaterials are designed to promote tissue adhesion, close incisions, seal corneal perforations, and prevent post-operative fluid leakage in various ophthalmic procedures. What sets ocular adhesives apart is their ability to reduce surgical time, minimize tissue trauma, and enhance patient comfort—especially crucial in delicate eye surgeries where precision is paramount. The increasing complexity of ophthalmic interventions, including cataract extraction, corneal transplants, LASIK, and glaucoma drainage procedures, has intensified demand for sealants that provide strong adhesion under wet conditions. Fibrin-based adhesives, polyethylene glycol (PEG) hydrogels, cyanoacrylate glues, and newer bioengineered polymers are among the most widely adopted solutions, each suited for specific clinical needs. For example, fibrin sealants are preferred for their biocompatibility and biodegradability, while cyanoacrylates are favored in emergency scenarios due to their rapid polymerization. The growing use of minimally invasive surgeries has further bolstered the need for these adhesives, particularly as microincisions and sutureless procedures become more commonplace. Additionally, these sealants play a critical role in reducing the risk of endophthalmitis, astigmatism, and other complications associated with traditional suturing. As surgical outcomes and patient experience become key performance metrics in modern ophthalmology, ocular adhesives and sealants are emerging as indispensable tools in achieving superior clinical results with fewer complications and quicker recovery times.

How Are Global Demographics and Eye Disorder Trends Influencing Market Demand?

The global surge in age-related eye disorders and the increasing volume of ophthalmic procedures are driving significant demand for ocular adhesives and sealants. As populations age, conditions such as cataracts, glaucoma, macular degeneration, and diabetic retinopathy are becoming increasingly prevalent, particularly in North America, Europe, and Asia-Pacific. The World Health Organization estimates that over 2 billion people globally have a vision impairment, much of which could be addressed through surgical intervention—underscoring the growing need for supportive surgical materials like adhesives and sealants. Furthermore, increased access to healthcare in emerging economies is expanding the number of people undergoing elective and corrective eye surgeries, from refractive surgeries to pterygium removal. Pediatric ophthalmology is also seeing a rise in the adoption of adhesives to manage congenital anomalies and trauma-related injuries, where sutures can be impractical or cause long-term discomfort. In addition to clinical volume, heightened patient expectations for quick recovery and improved cosmetic outcomes are accelerating the shift toward sutureless solutions. Regions like Asia-Pacific are experiencing a particularly sharp growth curve due to a combination of high surgical volume, increasing per capita health expenditure, and government investments in ophthalmic infrastructure. Simultaneously, global health initiatives focused on preventing blindness are pushing for the adoption of advanced surgical tools in low-resource settings, further catalyzing demand. As the epidemiological burden of ocular diseases rises and surgical access expands, the global market for adhesives and sealants is poised to play a vital role in modernizing eye care delivery.

Is Innovation in Biomaterials Revolutionizing the Landscape of Ocular Sealants?

Indeed, technological advancements in biomaterials and formulation science are significantly reshaping the ocular adhesives and sealants market. Innovations are primarily focused on improving biocompatibility, transparency, adhesion strength, and biodegradation profiles, ensuring that sealants can safely integrate into sensitive ocular tissues without eliciting inflammation or toxicity. Next-generation PEG-based hydrogels are gaining momentum for their ability to form flexible, transparent seals that maintain ocular clarity—a critical requirement in vision-centric applications. Researchers are also exploring novel cross-linking chemistries that enable faster curing under light activation or body temperature, which simplifies intraoperative use. Meanwhile, bioengineered adhesives inspired by natural compounds—such as gelatin, silk fibroin, and mussel-derived proteins—are being developed to combine strong adhesion with enhanced healing properties. Another exciting area is the integration of drug delivery capabilities into ocular sealants, allowing for post-surgical release of anti-inflammatory or antibiotic agents, thereby reducing the need for separate topical medications. Additionally, nanotechnology is playing a role in designing adhesives with enhanced mechanical strength and antimicrobial properties. On the manufacturing side, innovations in sterile packaging, single-use applicators, and dual-syringe delivery systems are streamlining surgical workflows and minimizing contamination risk. Regulatory agencies are increasingly supporting these innovations by fast-tracking approvals for products that demonstrate significant clinical benefit. As the boundaries between therapeutic materials and surgical aids continue to blur, ocular adhesives and sealants are evolving into multifunctional platforms that enhance both surgical efficiency and patient safety.

What Factors Are Fueling the Accelerated Growth of the Ocular Adhesives and Sealants Market?

The growth in the ocular adhesives and sealants market is driven by several factors centered on clinical innovation, rising surgical volumes, and evolving patient care standards. One of the primary drivers is the increasing global frequency of ophthalmic surgeries, fueled by the rising incidence of age-related eye diseases and greater patient access to vision care services. Technological progress in minimally invasive and micro-incisional techniques has further increased the demand for non-suturing solutions that maintain ocular integrity without compromising healing. From a materials standpoint, the development of fast-acting, biocompatible, and transparent adhesives is opening new applications in corneal, conjunctival, and scleral repairs. In the outpatient surgical setting, the use of adhesives can significantly reduce operating room time and follow-up care, making them a cost-effective solution for high-volume centers. Patient preference also plays a key role—today’s patients are more informed and more likely to seek procedures with shorter recovery periods and fewer complications, increasing demand for products that improve post-operative comfort and healing. On the commercial side, increasing investments from both established players and med-tech startups are driving rapid product innovation and expanding global distribution networks. Regulatory approvals in major markets like the U.S., EU, and Japan are accelerating market entry for new products, while rising R&D collaboration between academic institutions and private companies is pushing the frontiers of biomaterial science. Additionally, supportive reimbursement frameworks in developed regions and growing surgical capacity in developing countries are creating fertile ground for market expansion. Collectively, these dynamics are propelling the ocular adhesives and sealants market into a phase of sustained and transformative growth.

SCOPE OF STUDY:

The report analyzes the Ocular Adhesives and Sealants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Type (Natural Ocular Adhesives & Sealants, Synthetic Ocular Adhesives & Sealants); Application (Tissue Engineering Application, Conjunctival Surgery Application, Refractive Surgery Application, Vitreo-Retinal Surgery Application, Corneal Surgery Application); End-Use (Ophthalmic Clinics End-Use, Hospitals End-Use, Ambulatory Surgery Centers End-Use)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

• 3M Company
• AccuPS
• Advanced Medical Solutions Group plc
• Aesculap (a division of B. Braun)
• B. Braun Melsungen AG
• Baxter International Inc.
• Becton, Dickinson and Company
• BIOFLEX
• Cohera Medical, Inc.
• CryoLife, Inc.
• Everett Surgical
• GluStitch Inc.
• Integra LifeSciences Holdings Corporation
• Johnson & Johnson
• Medtronic plc
• Ocular Therapeutix, Inc.
• Reliance Life Sciences
• Smith & Nephew plc
• Stryker Corporation
• Sutures India Pvt. Ltd.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.